Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: A KASID prospective multicenter cohort study

Seung Yong Shin, Soo Jung Park, Young Kim, Jong Pil Im, Hyo Jong Kim, Kang Moon Lee, Ji Won Kim, Sung Ae Jung, Jun Lee, Sang Bum Kang, Sung Jae Shin, Eun Sun Kim, You Sun Kim, Tae Oh Kim, Hyun Soo Kim, Dong Il Park, Hyung Kil Kim, Eun Soo Kim, Young Ho Kim, Do Hyun KimDennis Teng, Jong Hwa Kim, Wonyong Kim, Chang Hwan Choi, behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: A KASID prospective multicenter cohort study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry